Edition:
United Kingdom

People: Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

138.46USD
3:40pm BST
Change (% chg)

$-0.32 (-0.23%)
Prev Close
$138.78
Open
$139.10
Day's High
$139.45
Day's Low
$138.18
Volume
45,135
Avg. Vol
608,544
52-wk High
$197.00
52-wk Low
$125.84

Meury, William 

Mr. William Meury is Chief Commercial Officer of Allergan Plc., since May 2016. Mr. Meury is the Chief Commercial Officer of Allergan and has served in this role since May 2016, having previously served as President, Branded Pharma from March 2015 and Executive Vice President, Commercial, North American Brands from July 2014. Mr. Meury served as Executive Vice President, Sales and Marketing at Forest prior to its acquisition by Allergan (then known as Actavis). He joined Forest in 1993 and held multiple roles of increasing responsibility in Marketing, New Products, Business Development, and Sales. Before joining Forest, Mr. Meury worked in public accounting for Reznick Fedder & Silverman and in financial reporting for MCI Communications. He received a B.S. in Economics from the University of Maryland. Mr. Meury serves on the Board of Directors of several organizations, including The Jed Foundation, International Council of Ophthalmology Foundation, and The Allergan Foundation.

Basic Compensation

Total Annual Compensation, USD 3,896,470
Restricted Stock Award, USD 7,162,720
Long-Term Incentive Plans, USD --
All Other, USD 23,815
Fiscal Year Total, USD 11,083,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 11,807 1,121,760.00